Assessment of antimicrobial activity of [1,2,4]triazolo[4, 3-a]quinoxaline derivatives individually and in combination with levofloxacin
Abstract
The need to develop new and effective antimicrobial compounds has become a fundamental requirement of the therapeutic system worldwide. In this study, a series of synthetic 4-amino triazoloquinoxaline derivatives were designed and synthesized. The chemical structure of these compounds was confirmed using spectroscopic methods (1H-NMR, 13C-NMR, FT-IR, and MS). Their antimicrobial activity against several Gram-positive and Gram-negative bacteria was then evaluated. The results of biological experiments showed that the synthetic compounds 5b, 5d, and 5h derivatives have moderate antimicrobial activity against Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, Pseudomonas aeruginosa, and Candida albicans compared to some standard drugs. Non-toxic compounds were selected based on MTT and hemolysis assays, and their synergistic effect in combination with levofloxacin (LEV) was investigated. The findings confirmed the effectiveness of combination therapy in reducing the dose of LEV, compounds 5d and 5h against S. aureus and S. epidermidis, as well as 5d and 5b against resistant isolates of MRSA and P. aeruginosa, respectively, with a fractional inhibitory concentration index ≤ 0.5. Field-emission scanning electron microscopy confirmed the complete damage of S. aureus, S. epidermidis, and P. aeruginosa following exposure to the combination therapy of compounds 5b, 5d, and 5h with LEV. This new synergistic therapy has the potential to be used as a novel approach of…
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.